SEATTLE, Feb. 22, 2018 -- Global supercomputer leader Cray Inc. (Nasdaq:CRAY) announced today that Peter Ungaro, President and Chief Executive Officer, and Paul Hiemstra, Corporate Treasurer and Investor Relations Contact, will present at the Morgan Stanley Technology, Media and Telecom Conference at the Palace Hotel in San Francisco, Calif. The Cray presentation will be held on Tuesday, February 27, at 2:05 p.m. PT (5:05 p.m. ET).
Peter Ungaro and Paul Hiemstra will also present at the Pacific Crest KeyBanc Emerging Technology Summit at the Park Central Hotel in San Francisco, Calif. The Cray presentation will be held on Wednesday, February 28, at 9:00 a.m. PT (12:00 p.m. ET).
The Cray presentations will be available to the public via live audio webcast. To listen to the webcast, go to the Investors section of the Cray website at http://investors.cray.com. An archived version of the webcast will be available on the Cray website for 90 days.
About Cray Inc.
Global supercomputing leader Cray Inc. (Nasdaq:CRAY) provides innovative systems and solutions enabling scientists and engineers in industry, academia and government to meet existing and future simulation and analytics challenges. Leveraging more than 40 years of experience in developing and servicing the world’s most advanced supercomputers, Cray offers a comprehensive portfolio of supercomputers and big data storage and analytics solutions delivering unrivaled performance, efficiency and scalability. Cray’s Adaptive Supercomputing vision is focused on delivering innovative next-generation products that integrate diverse processing technologies into a unified architecture, allowing customers to meet the market’s continued demand for realized performance. Go to www.cray.com for more information.
Cray Media:
Nick Davis
206/701-2123
[email protected]
Investors:
Paul Hiemstra
206/701-2044
[email protected]


Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Explores AI Content Marketplace With Media Publishers
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



